Evidence map›Paper›PMID 25482187›Full record

SynthesisCritical care (London, England)2014

Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review.

Han Chen, Rong-Guo Yu, Ning-Ning Yin, Jian-Xin Zhou

Registry-linked trialOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Critical care (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03549923 (Impact of Early CRRT Intervention in Patients Receiving VA-ECMO Support on 30-day Mortality), which is not on this map. Cited by 76 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03549923 phase4completednot on this mapstarted 2018, after this paper: background citation

Impact of Early CRRT Intervention in Patients Receiving VA-ECMO Support on 30-day Mortality: A Randomized Controlled Trial

TypeinterventionalSponsorBeijing Anzhen HospitalRan2018 to 2023Enrolled131ConditionsCardiogenic ShockArmsSimultaneous CRRT, Conventional-indication CRRT, Esmolol, Standard care
3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 2 syntheses or guidelines pooled it, 193 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Han ChenDepartment of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China. baojr2@163.com.
Rong-Guo YuSurgical Intensive Care Unit, Fujian Provincial Clinical College of Fujian Medical University, Fuzhou, 350001, Fujian, China. garyyrg@yahoo.com.
Ning-Ning YinDepartment of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China. yinningning2008@126.com.
Jian-Xin ZhouDepartment of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China. zhoujx.cn@gmail.com.
Capital Medical University · CNBeijing Tian Tan Hospital · CNFujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionExtracorporeal membrane oxygenation (ECMO) is used in critically ill patients presenting acute cardiac and/or pulmonary dysfunctions, who are at high risk of developing acute kidney injury and fluid overload. Continuous renal replacement therapy (CRRT) is commonly used in intensive care units (ICU) to provide renal replacement and fluid management. We conducted a review to assess the feasibility, efficacy and safety of the combination of ECMO and CRRT and to illustrate the indications and methodology of providing renal replacement therapy during the ECMO procedure.

methodWe searched for all published reports of a randomized controlled trial (RCT), quasi-RCT, or other comparative study design, conducted in patients undergoing ECMO plus CRRT. Two reviewers independently selected potential studies and extracted data. We used the modified Jadad scale and the Newcastle-Ottawa for quality assessment of RCTs and non-RCTs, respectively. Statistical analyses were performed using RevMan 5.2.

resultsWe identified 19 studies meeting the eligibility criteria (seven cohort, six case control, one historically controlled trial and five studies of technical aspects). There are three major methods for performing CRRT during ECMO: 'independent CRRT access', 'introduction of a hemofiltration filter into the ECMO circuit (in-line hemofilter)' and 'introduction of a CRRT device into the ECMO circuit'. We conducted a review with limited data synthesis rather than a formal meta-analysis because there could be greater heterogeneity in a systematic review of non-randomized studies than that of randomized trials. For ECMO survivors receiving CRRT, overall fluid balance was less than that in non-CRRT survivors. There was a higher mortality and a longer ECMO duration when CRRT was added, which may reflect a relatively higher severity of illness in patients who received ECMO plus CRRT.

conclusionsThe combination of ECMO and CRRT in a variety of methods appears to be a safe and effective technique that improves fluid balance and electrolyte disturbances. Prospective studies would be beneficial in determining the potential of this technique to improve the outcome in critically ill patients.

Indexed as

Acute Kidney InjuryCase-Control StudiesCohort StudiesCombined Modality TherapyCritical IllnessExtracorporeal Membrane OxygenationHospital MortalityHumansIntensive Care UnitsRandomized Controlled Trials as TopicRenal Replacement Therapy

Identifiers

PMID25482187
PMCPMC4277651
OpenAlexW2086538506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.